Related Experiment Video
Updated: Feb 13, 2026

Subcutaneous Infection of Methicillin Resistant Staphylococcus Aureus MRSA
Published on: February 9, 2011
A large retrospective cohort study of cefazolin compared with flucloxacillin for methicillin-susceptible
J S Davis1, J Turnidge2, Syc Tong3
1Global and Tropical Health Division, Menzies School of Health Research, Darwin, NT, Australia; Department of Infectious Diseases, John Hunter Hospital, Newcastle, NSW Australia.
Background And Objectives:
Antistaphylococcal penicillins (ASPs) are recommended as first-line treatment for invasive infections caused by methicillin-susceptible Staphylococcus aureus (MSSA). Cefazolin is an alternative option, but there is theoretical concern about its use as some MSSA strains produce beta-lactamases active against cefazolin. The study compared the outcomes in patients with MSSA infections treated with flucloxacillin and cefazolin.
Methods:
We analysed data from The Australia and New Zealand Co-operative Outcomes of Staphylococcal Sepsis (ANZCOSS) observational study, which included all consecutive unique episodes of Staphylococcus aureus bacteraemia from 27 hospital-based or independent microbiology laboratories from January 2007 to September 2013. In this retrospective analysis of prospectively collected data, we compared 30-day all-cause mortality in patients with MSSA bacteraemia treated with flucloxacillin to that in patients treated with cefazolin.
Results:
We included data from 7312 episodes of MSSA bacteremia and found no difference in 30-day mortality in those treated with flucloxacillin (731/6520 [11.2%, 95% CI 10.9-12.5%]) compared to cefazolin (83/792 [10.7%, 95% CI 8.4-12.8%]), OR 0.93 (95% CI 0.72-1.17). In a propensity-adjusted analysis, mortality remained non-significantly lower in the cefazolin group (aOR 0.86 [95% CI 0.65-1.14]).
Conclusions:
This study supports the results from previous observational studies from other regions, while extending them to Australasia and to a much larger number of patients. Although this observational study indicates cefazolin is likely to have equivalent or superior outcomes to ASPs for MSSA bacteraemia, this can only be convincingly proven by a properly designed randomised controlled trial.
Insights
For methicillin-susceptible Staphylococcus aureus (MSSA) infections, cefazolin showed similar 30-day mortality outcomes compared to flucloxacillin. This large observational study in Australasia supports cefazolin as an effective treatment option for MSSA bacteremia.
Area of Science:
- Infectious Diseases
- Pharmacology
- Clinical Microbiology
Background:
- Antistaphylococcal penicillins (ASPs) are standard treatment for invasive methicillin-susceptible Staphylococcus aureus (MSSA) infections.
- Cefazolin is an alternative, but concerns exist regarding MSSA strains producing beta-lactamases that may reduce its efficacy.
Purpose of the Study:
- To compare treatment outcomes between flucloxacillin and cefazolin for patients with MSSA infections.
- To evaluate 30-day all-cause mortality in MSSA bacteremia patients treated with either flucloxacillin or cefazolin.
Main Methods:
- Retrospective analysis of prospectively collected data from the Australia and New Zealand Co-operative Outcomes of Staphylococcal Sepsis (ANZCOSS) study.
- Inclusion of consecutive unique episodes of Staphylococcus aureus bacteremia from January 2007 to September 2013.
- Comparison of 30-day all-cause mortality between patients treated with flucloxacillin versus cefazolin.
Main Results:
- Data from 7312 episodes of MSSA bacteremia were analyzed.
- No significant difference in 30-day mortality was observed between flucloxacillin (11.2%) and cefazolin (10.7%) groups.
- Propensity-adjusted analysis also showed non-significantly lower mortality in the cefazolin group (aOR 0.86).
Conclusions:
- This study, the largest to date from Australasia, supports previous findings on cefazolin's efficacy for MSSA bacteremia.
- Observational data suggest cefazolin offers equivalent or superior outcomes compared to ASPs for MSSA bacteremia.
- A randomized controlled trial is recommended to definitively confirm cefazolin's effectiveness.
Related Concept Videos
Magnetic Susceptibility and Permeability
When diamagnetic materials are placed under an external magnetic field, the moments opposite to the field are induced. Hence, the susceptibility for diamagnets has a minimal negative value of 10-5–10-6. Since...
Susceptibility, Permittivity and Dielectric Constant
Comparing Copy Number Variations and SNPs
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
Comparative Excretory Systems
Comparing Experimental Results: Student's t-Test
Comparing the Survival Analysis of Two or More Groups

